[HTML][HTML] Immunological and virological triggers of type 1 diabetes: insights and implications

JRN Lemos, K Hirani, M von Herrath - Frontiers in Immunology, 2024 - frontiersin.org
Type 1 diabetes (T1D) is caused by an autoimmune process which culminates in the
destruction of insulin-producing beta cells in the pancreas. It is widely believed that a …

Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response

P Naughton, F Enright, B Lucey - Current Opinion in Infectious …, 2024 - journals.lww.com
Infectious mononucleosis: new concepts in clinical presentat... : Current Opinion in Infectious
Diseases Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and …

Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders

A Bauer, H Hegen, M Reindl - Expert Review of Molecular …, 2024 - Taylor & Francis
Introduction Body fluid markers could be helpful to predict the conversion into clinically
definite multiple sclerosis (MS) in people with a first demyelinating event of the central …

Infectious mononucleosis and risk of multiple sclerosis: Proxy or culprit?

H Hjalgrim, K Rostgaard - Multiple Sclerosis Journal, 2024 - journals.sagepub.com
Goldacre's study is a valuable contribution to the epidemiological literature on EBV's
association with MS risk, 9 significantly extending previous observations of an increased risk …

Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003–2023

R Goldacre - Multiple Sclerosis Journal, 2024 - journals.sagepub.com
Background: Epstein–Barr virus (EBV) is thought to be a necessary causative agent in the
development of multiple sclerosis (MS). Infectious mononucleosis (IM), which occurs up to …

What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases

JK Park, EB Lee, KL Winthrop - Annals of the Rheumatic Diseases, 2024 - ard.bmj.com
Messenger RNA (mRNA) vaccines as a novel vaccine platform offer new tools to effectively
combat both emerging and existing pathogens which were previously not possible. The …

The Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis cohort population structure and disease etiology

AM Pagalilauan, E Everest, S Rachimi, D Reich… - medRxiv, 2024 - medrxiv.org
Background Previous genetic and epidemiological studies have examined subpopulations
from the Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis …

[HTML][HTML] Head trauma results in manyfold increased risk of multiple sclerosis in genetically susceptible individuals

E Johansson, L Alfredsson, P Strid, I Kockum… - Journal of Neurology …, 2024 - jnnp.bmj.com
Background Large register-based studies have reported an association between head
trauma and increased risk of multiple sclerosis (MS). We aimed to investigate possible …

Elucidating Neuroinflammation in Multiple Sclerosis by Network Analysis

NC Welsh - 2024 - digitalcommons.dartmouth.edu
Multiple sclerosis (MS) is a heterogeneous disease, differing on many variables, including
disease course, sex, and overall activity. Key characteristics of the disease encompass …

[PDF][PDF] Ultra-low doses of microARNs restore a strong immune response in patients with Chronic Active Epstein-Barr Virus infection (CAEBV)

N Bahi-Jaber, G Glady - 2024 - srrjournals.com
Abstract Chronic active Epstein-Barr Virus infection (CAEBV) is an abnormal response of the
immune system to EBV infection, characterized by the absence of anti-EBNA (EBV Nuclear …